<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pharmaceutical company and software Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharmaceutical+company+and+software.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pharmaceutical company and software]]></description>
	<s:counts start="0" returned="20" found="65" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Novartis, Boehringer Start Using Twitter Accounts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001062/novartis-boehringer-start-using-twitter-accounts/]]></link>
		<description><![CDATA[AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive.    Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Feb 2009 10:02:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/twitter.html"><![CDATA[Twitter]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/bi+site.html"><![CDATA[BI Site]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Johnson & Johnson, Abbott, Forest, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000621/pharma-roundup-johnson-johnson-abbott-forest-and-more/]]></link>
		<description><![CDATA[An unhappy wind blows through Johnson & Johnson -- Patent expirations are taking their toll on the drug giant, which has seen profits slip and year-over-year sales drop 11 percent. Analysts predict an acquisition. [Source: Forbes, via Corey Nahman]    Abbott's diversification brings financial health -- The yin...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 21 Jan 2009 16:48:48 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Daiichi's Ranbaxy Write-Down, Merck's UPS Deal, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000562/pharma-roundup-daiichis-ranbaxy-write-down-mercks-ups-deal-and-more/]]></link>
		<description><![CDATA[Daiichi to lose $4 billion on Ranbaxy. UPS to run Merck distribution centers. Taro rejects Sun. U.S. prescription sales slump. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 16:40:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/united+parcel+service+of+america+inc..html"><![CDATA[United Parcel Service Of America Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sun+microsystems+inc..html"><![CDATA[Sun Microsystems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JAVA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UPS</category>
		<category domain="tickers">MRK,JAVA,UPS</category>
	</item>
	<item>
		<title><![CDATA[Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000553/starved-of-news-press-speculates-on-deals-for-abbott-pfizer-and-wyeth/]]></link>
		<description><![CDATA[New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 Jan 2009 13:20:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/abbott+laboratories+inc..html"><![CDATA[Abbott Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/mahady.html"><![CDATA[Mahady]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">ABT,PFE,WYE</category>
	</item>
	<item>
		<title><![CDATA[Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000547/drug-makers-gave-lobbyists-an-xmas-gift-millions-more-to-lobby-obama-administration/]]></link>
		<description><![CDATA[A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 31 Dec 2008 11:36:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/administration.html"><![CDATA[Administration]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+drug.html"><![CDATA[Biotech Drug]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Obama May Decrease Drug Revenue, Strong Viagra and Cialis Sales, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000330/pharma-roundup-obama-may-decrease-drug-revenue-strong-viagra-and-cialis-sales-and-more/]]></link>
		<description><![CDATA[Obama health plan provision could cost pharma billions in revenue; Viagra and Cialis sales still swelling; Glaxo opts for transparency; contract manufacturing worth $20 billion by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 23 Oct 2008 17:16:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/obama+health+plan.html"><![CDATA[Obama Health Plan]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Daiichi and Ranbaxy, Generics and Staff Shake-Ups at Novartis, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000311/pharma-roundup-daiichi-and-ranbaxy-generics-and-staff-shake-ups-at-novartis-and-more/]]></link>
		<description><![CDATA[Daiichi buys 20% stake in Ranbaxy; at Novartis, executives and jobs on the move, and sinking profits from generics; Wisconsin doctors ban gifts from pharma companies. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 20 Oct 2008 16:52:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[Generic]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/daiichi.html"><![CDATA[Daiichi]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[Generic]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/daiichi.html"><![CDATA[Daiichi]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[New CEO Veihbacher, Plucked From the U.S., Could De-Frenchify Sanofi]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000210/new-ceo-veihbacher-plucked-from-gsk-in-the-us-could-de-frenchify-sanofi/]]></link>
		<description><![CDATA[Paris-based pharma giant Sanofi-Aventis may be about to get a little less French with the appointment of Chris Viehbacher, formerly head of U.S. pharma at GlaxoSmithKline, as its new CEO.    The company gets more than half of its revenues on its top drugs from the U.S. (as...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 10 Sep 2008 09:28:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Unlocking The Potential For High Performance Through The Pharmaceutical Supply Chain]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=953347]]></link>
		<description><![CDATA[Profitable growth in nowadays' pharmaceutical industry requires a new kind of supply chain - one that plans and executes globally, across the extended enterprise and throughout the product life cycle. By changing their global operating model, redefining core competencies and capabilities, and collaborating with effective partners, including large, strategic customers,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 30 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/supply+chain.html"><![CDATA[Supply Chain]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/high-performance.html"><![CDATA[High-performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Seizing China's Pharma Opportunity]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=950905]]></link>
		<description><![CDATA[China's pharmaceutical market is growing by upward of 20 percent a year, but global drug companies still must capture its full potential. In less than a decade, China will be transformed from a secondary pharmaceutical market into the world's fifth largest. Companies aiming to capture a large chunk of it...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 01 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/mckinsey+%2526+co..html"><![CDATA[McKinsey & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
	</item>
	<item>
		<title><![CDATA[Pharmaceutical Jobs Offer Good Pay]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=375984]]></link>
		<description><![CDATA[Pharmaceutical jobs belong in the healthcare industry, a fast growing industry. An aging population and new developments in diagnosis and treatment leading to increased use of medication are the main factors leading this growth. The pharmaceutical industry itself is a big part of this growth story. In addition to bringing...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[Job]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
	</item>
	<item>
		<title><![CDATA[Data Mining In Pharmaceutical Marketing And Sales Analysis]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=328492]]></link>
		<description><![CDATA[This presentation explains the data mining in pharmaceutical marketing and sales analysis. ]]></description>
		<s:doctype><![CDATA[Presentations]]></s:doctype>
		<pubDate>Mon, 18 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/north+carolina+state+university.html"><![CDATA[North Carolina State University]]></category>
		<category domain="http://resources.bnet.com/topic/data+mining.html"><![CDATA[Data Mining]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/databases.html"><![CDATA[Databases]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
	</item>
	<item>
		<title><![CDATA[Endo Pharmaceuticals' Unique Business Needs Met By UPS]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1174137]]></link>
		<description><![CDATA[Endo Pharmaceuticals was formed by three executives in 1997. With a portfolio of highly regarded products, such as Percocet tablets, Endo's vision was to become the premier pharmaceutical company focused on pain management. To ensure success, Endo's founders knew that they had to marry their business plan to their supply...]]></description>
		<s:doctype><![CDATA[Case studies]]></s:doctype>
		<pubDate>Fri, 02 Feb 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/united+parcel+service+of+america+inc..html"><![CDATA[United Parcel Service Of America Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain.html"><![CDATA[Supply Chain]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/endo.html"><![CDATA[Endo]]></category>
		<category domain="http://resources.bnet.com/topic/transportation.html"><![CDATA[Transportation]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UPS</category>
		<category domain="tickers">UPS</category>
	</item>
	<item>
		<title><![CDATA[Flexible ERP Injects Massive Savings]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=272175]]></link>
		<description><![CDATA[Microsoft Dynamics AX ERP Axapta as was is doing sterling service at Danish food and cosmetics gums and pastes manufacturer Gumlink and its gum-based drugs business unit Fertin Pharma. The system proved flexible enough to link easily with its 100-plus other software packages across the company is three production sites,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 01 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[Food]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/erp.html"><![CDATA[ERP]]></category>
		<category domain="http://resources.bnet.com/topic/findlay+publications.html"><![CDATA[Findlay Publications]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+resource+planning+%2528erp%2529.html"><![CDATA[Enterprise Resource Planning (ERP)]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
	</item>
	<item>
		<title><![CDATA[BASF automates bulk pharmaceuticals production: beginning with a SCADA system to improve purine production at its Minden, Germany, pharmaceuticals plant, BASF has expanded use of batch software to respond to daily market demands and unexpected plant-floor]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3072/is_200602/ai_n18802862]]></link>
		<description><![CDATA[Demand for bulk pharmaceutical products, such as caffeine,  theophylline, ephedrine, and pseudoephedrine, has grown so consistently  that BASF's Minden, Germany, pharmaceutical plant existed in a  near-continual state of expansion to meet production r    Demand for bulk pharmaceutical products, such as caffeine,  theophylline, ephedrine,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Feb 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/scada.html"><![CDATA[SCADA]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="tickers">BASF Y</category>
	</item>
	<item>
		<title><![CDATA[U.S. Equity Strategy: The Health of Health Care]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=148477]]></link>
		<description><![CDATA[This article reports on the latest state of the healthcare market. Recent negative news in the drug sector has pushed down pharmaceutical stocks and provides an entry point given attractive valuations and dividends, as well as relative 2006 EPS growth prospects. Seasonal trading patterns also should benefit both pharmaceutical and...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/citigroup+inc..html"><![CDATA[Citigroup Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">C</category>
		<category domain="tickers">C</category>
	</item>
	<item>
		<title><![CDATA[SAS Supports Launch of Inaugural Pharmaceutical Users Software Exchange in Heidelberg; Knowledge Exchange Event for SASŪ Professionals in the Pharmaceutical Industry]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_August_30/ai_n14936688]]></link>
		<description><![CDATA[HEIDELBERG, Germany -- SAS, the leader in business intelligence, will host the first-ever Pharmaceutical Users Software Exchange PhUSE Oct. 10-12, in the historic city of Heidelberg, Germany, at the Kongresshaus Stadthalle Heidelberg, opposite SAS EMEA Headquarters. The inaugural PhUSE event is being organized by a committee of pharmaceutical industry leaders...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 30 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sas+institute.html"><![CDATA[SAS Institute]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/knowledge.html"><![CDATA[knowledge]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[software]]></category>
	</item>
	<item>
		<title><![CDATA[Dendrite Signs Comprehensive Software Services Agreement with Esprit Pharma; Esprit Looks to Dendrite's WebForce&#153; Express and Full Suite of Sales Support Services to Help Foster Growth and Market Expansion]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_August_23/ai_n14928339]]></link>
		<description><![CDATA[BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical and compliance solutions for the life science and pharmaceutical industries, today announced that Esprit Pharma, Inc. has signed a comprehensive, three-year several million dollar software and services agreement with Dendrite. This customer win was previously...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 23 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/dendrite+international+inc..html"><![CDATA[Dendrite International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Oxymoron No More: The Potential of Nonprofit Drug Companies to Deliver on the Promise of Medicines for the Developing World]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=153273]]></link>
		<description><![CDATA[Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. The paper discusses the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in developing countries. Using the experience...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 01 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/developing+country.html"><![CDATA[Developing Country]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/project+hope.html"><![CDATA[Project HOPE]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/free+trade.html"><![CDATA[Free Trade]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
	</item>
	<item>
		<title><![CDATA[Building Supply Chain Capabilities in the Pharmaceutical Industry: Part 2: Winning Supply Chain Capabilities]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=159632]]></link>
		<description><![CDATA[This paper describes the trends that are having the greatest impact on sales and marketing, channel management, and new product development and rollout in the pharmaceutical industry. Successful pharmaceutical companies actively seek to position their organizations for future profitability by anticipating increased competition and the demise of high margins. This...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 15 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain.html"><![CDATA[Supply Chain]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
	</item>
</channel>
</rss>
